Latest Drugs Stories
Today, NCPDP addressed the FDA, CDER and ODAC meeting that met to review and make a recommendation on what may be the first biosimilar to receive FDA approval in the U.S., and potentially develop
The Report OTC Market in Central Europe 2014 Comparative analysis and development forecasts for 2014-2019 provides information on pricing, market analysis, shares, forecast, and company profiles
New research reveals nearly 60% of patients using opioid painkillers are combining multiple prescriptions with potentially serious safety risks; Novus Medical Detox Center calls for stricter monitoring
QUÉBEC CITY, Dec. 29, 2014 /PRNewswire/ - Aeterna Zentaris Inc.
New report from Kantar Health shows opportunities for biosimilars are high in oncology, low in rheumatoid arthritis in China. Shanghai, China (PRWEB) December
In light of a recent study demonstrating the connection between adolescents' use of anti-anxiety and sleep medications and subsequent prescription drug abuse, Novus Medical Detox Center calls for parental
Biosimilar stakeholders urge the FDA to pass final regulations related to the drugs at a recent conference on biosimilars, reports Atlantic Information Services’ Specialty Pharmacy News in its
Data also reveals modest improvement in number of chronic pain patient samples containing prescribed medications BALTIMORE, Dec.
~Partnership for Drug-Free Kids Responds to 2014 Monitoring the Future Study NEW YORK, Dec.